Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India
Introduction
Cancer is a major public health problem and cause of death worldwide. According to WHO, cancer accounted for 7.6 million deaths in 2008, which is projected to rise with an estimated 13.1 million deaths in 2030. Breast cancer (BC) is the most common cancer among women, accounting for 25% of all new cancer cases [1]. In India, BC is the leading cancer diagnosed in women overtaking cervical cancer [2]. A number of risk factors are associated with BC like age, family history, genetic mutation, breast density, reproductive factors, nutritional status, obesity, alcohol use and socioeconomic status (SES). Epidemiological and clinical evidence supports that nutrition in its broadest sense, plays a role in BC [3], [4]. Evidence suggests that vitamin D intake (ergocalciferol and cholecalciferol) in association with calcium may be protective against BC [5], [6], [7]. Women with 25(OH)D concentrations ≥40 ng/ml have a significantly lower risk of cancer (∼70%) compared with concentrations <20 ng/ml [8].
Vitamin D has been shown to have anti-carcinogenic properties like effects on cell proliferation and differentiation [9]. Synthesis of 1,25-dihydroxyvitamin D in breast tissue may contribute to maintenance of normal cell function, which could be impaired in vitamin D deficiency. A large number of Indian women are affected with BC. The literature available on the nutritional risk factors in BC has provided mixed results [10]. Hence, the present case control study aimed to investigate the nutritional factors and status of serum 25(OH)D levels and the risk of BC was conducted.
Section snippets
Materials and methods
A hospital based case control study was conducted. Women (cases) with confirmed diagnosis of BC attending a tertiary health care hospital located at latitude of 28.56N and longitude of 77.21E in the national capital territory of India were enrolled. Patients were referred to the current hospital from peripheral hospitals, clinics or physicians in private practices.
Considering average serum 25(OH) levels in cases as 9.5 ± 6.5 ng/ml and controls as 15 ± 13 ng/ml [11] Power of 90 with alpha equal to 5%,
Results
A total of 100 cases with confirmed BC matched with equal number of healthy controls of similar age and SES were included in this study. The mean age of cases and controls was 45 ± 9 and 46 ± 10 years respectively. Baseline characteristics of cases and controls are shown in Table 1. It was found that a high percentage of women (69%) with BC were in the age group of 28–48 years. On the basis of American Joint Committee on Cancer (AJCC) classification for staging of BC, it was found that (83%) of the
Discussion
The results of the present study revealed that majority (69%) of BC cases were in the age group of 28–48 years. In Asia, BC incidence peaks among women in their 40s which are around 20 years earlier compared to women from western countries [18]. Breast cancer at younger age has been linked to genetic/hereditary factors [19]. However there is no strong evidence to support it. Our study had majority (62%) of cases from middle and lower SES with primary or no level of education. A recent study
Limitations to the study
The potential confounding variables such as reproductive risk factors, physical activity, breast density, genetic factors, body mass index, smoking status, and education level were not included in the analysis. Since the primary focus was on nutritional risk factors with status of vitamin D and calcium. It is possible that the effect of these factors might have masked the effect of association of nutritional risk factors with BC.
Acknowledgements
We are highly grateful to the Department of Biotechnology (DBT) for providing the grant for successful implementation of this study. I take this opportunity to express my deepest gratitude to Dr Afrozul Haq (Special Issue Managing Guest Editor, The Journal of Steroid Biochemistry and Molecular Biology) for guiding me all the way so far. I am highly grateful to the experienced reviewers, who, with their expert views and suggestions made me capable of improving my paper writing skills and
References (40)
Vitamin D and breast cancer
Ann. Epidemiol.
(2009)- et al.
Vitamin D status and breast cancer in Saudi Arabian women: case-control study
Am. J. Clin. Nutr.
(2013) - et al.
Performance evaluation of four 25-hydroxyvitamin D assays to measure 25-hydroxyvitamin D2
Clin. Biochem.
(2015) - et al.
Vegetable and fruit consumption and the risk of hormone receptor-defined breast cancer in the EPIC cohort
Am. J. Clin. Nutr.
(2016) - et al.
Global cancer statistics 2012
CA Cancer J. Clin.
(2015) Three Year Report of Population Based Cancer Registries 2009–2011
(2013)The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity and the prevention of cancer: a global perspective
Proc. Nutr. Soc.
(2008)- et al.
Diet and breast cancer
Curr. Oncol. Rep.
(2007) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States)
Cancer Causes Control
(2005)- et al.
Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies
PLoS One
(2013)
Serum 25-hydroxyvitamin D concentrations ≥40 ng/ml are associated with >65% lower cancer risk: pooled analysis of randomized trial and prospective cohort study
PLoS One
Molecular basis of the potential of vitamin D to prevent cancer
Curr. Med. Res. Opin.
Breast cancer survival among young women: a review of the role of modifiable lifestyle factors
Cancer Causes Control
Kuppuswamy’s socioeconomic scale: updating income ranges for the year 2012
Indian J. Public Health
Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation
Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline
J. Clin. Endocrinol. Metab.
LIAISON® 25 OH Vitamin D TOTAL Assay [Directional Insert]
Spectrum of breast cancer in Asian women
World J. Surg.
Breast cancer in young women
Nat. Rev. Clin. Oncol.
Cited by (19)
Reproductive factors, nutritional status and serum 25(OH)D levels in women with breast cancer: A case control study
2018, Journal of Steroid Biochemistry and Molecular BiologyCitation Excerpt :It was found that women with serum 25(OH)D (less than 20 ng/ml) and calcium levels (less than 10.5 mg/dl) had higher odds of having BC. Similar results have been documented earlier [26]. Vitamin D in association with calcium leads to suppression of proliferation induced by 17-beta estradiol and downregulation of estrogen receptors limiting the availability of free estrogen and thereby decreasing risk of BC.
Vitamin D and breast cancer: Indian perspective
2017, Clinical Nutrition ExperimentalCitation Excerpt :Recent research study on the nutritional risk factors in breast cancer revealed that more than 90% of women with breast cancer were suffering from vitamin D deficiency. The higher risk of BC was found to be associated with low serum 25(OH)D levels [52]. Association between vitamin D receptor (VDR) gene polymorphisms and BC have been investigated by a few studies [53,54].
Osteoprotegerin, Parathyroid Hormone and Vitamin D as Effective Factors on Serum-Urine Calcium Levels in Breast Cancer Patients
2022, Archives of Razi InstituteVitamin D: an essential adjuvant therapeutic agent in breast cancer
2022, Journal of International Medical ResearchSerum 25-Hydroxyvitamin D and the risk of breast cancer in women from Southern Morocco: A case-control study
2022, Mediterranean Journal of Nutrition and Metabolism